drugset / Trial / NCT06391827
A Study to Evaluate Safety, Tolerability, and PK of DA-7503 in Healthy Adult and Elderly Participants
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a double-blind, placebo-controlled, randomized, phase 1 study to evaluate safety, tolerability, and pharmacokinetics of orally administered DA-7503 after single and multiple ascending dose regimens in healthy adult and elderly participants
Timeline
- Start
- 2024-05-27
- Primary completion
- 2026-01-12
- Completion
- 2026-01-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DA-7503 | Unknown | — | Oral |
Indications
No indication recorded.